A particularly large amount of ink has been spilled to discredit—nay, stomp out—the inconvenient notion that vaccines might have something to do with autism spectrum disorder (ASD), which now affects 1 in 36 children in the U.S. Despite extensive high-level scientific fraud at the Centers for Disease Control and Prevention (CDC) to suppress evidence of a vaccine-autism link, the CDC has not been able to hide over 80 independent studies that connect the dots between the vaccine preservative thimerosal and autism. Other studies have pointed to additional vaccine-related culprits that may be contributing to ASD, including aluminum—used in a very high proportion of infant vaccines and recently reported in pathologically significant levels in the brains of individuals diagnosed with autism. The latest example is on display in a 2018 study published in JAMA Pediatrics titled “Vaccination patterns in children after autism spectrum disorder diagnosis and in their younger siblings.” The nine studies that the JAMA Pediatrics authors cite to “show” that autism is unrelated to vaccines are wholly inadequate to make any such assertion. Two of the studies are merely review articles published in 2001 and 2002, both written by the same corrupt CDC author who provides no original data on the subject. An additional paper headed up by the same author in 2004 has been shown to be fraudulent, as the five authors purportedly conspired to withhold measles-mumps-rubella (MMR) and autism data that implicated the MMR vaccine for specific subpopulations of children with ASD. Yet another of the papers cited by the JAMA Pediatrics authors, a 2003 paper involving thimerosal-containing vaccines in Denmark, was thoroughly debunked by a later CDC study that showed a reduction in ASD prevalence in Denmark after the removal of thimerosal from vaccines in 1992. The nine flimsy, flawed and out-and-out fraudulent studies that the JAMA Pediatrics authors cite as a basis for their contention that vaccines don’t cause autism focus only on thimerosal in vaccines and the MMR vaccine. Setting aside the issue of these studies’ poor quality, one has to ask, “What about the rest of the vaccine schedule?” It is essentially unstudied! In fact, in 2011, the Institute of Medicine stated that there were insufficient data to judge whether the diphtheria-tetanus-acellular pertussis (DTaP) vaccine—one of those included in the 2018 JAMA Pediatrics study—caused autism. The Institute acknowledged that there simply hadn’t been proper studies done by the CDC or other entities charged with vaccine safety in the U.S.
Mercury is a potent neurotoxin. Even the smallest amounts can cause cumulative adverse effects. Two of the most widespread forms of mercury exposure come from the organic compounds methylmercury (found in fish) and ethylmercury, which makes up 50% of the vaccine preservative thimerosal. The Agency for Toxic Substances and Disease Registry (ATSDR) affirms that young children and fetuses are particularly sensitive to harmful mercury-related effects such as “brain damage, mental retardation, incoordination, blindness, seizures and inability to speak.” This calls into question public health authorities’ aggressive peddling of annual flu shots—many of which contain thimerosal. The influenza vaccine guidelines target all children who are at least six months of age, with two closely spaced doses recommended for very young children in their “first season of vaccination.” They also target pregnant women and women who “might” be pregnant. Organic mercury can cross the blood-brain barrier, and numerous studies have fingered it as a major offender in increasing the risk of neurodevelopmental disorders such as autism spectrum disorder (ASD), tic disorders, delayed language and attention-deficit/hyperactivity disorder (ADHD). Shamefully, the Centers for Disease Control and Prevention (CDC) refuses to admit that mercury is an ASD risk factor. Instead, it has been left up to other researchers to continue to focus attention on the compelling relationship between mercury and ASD.
With the addition of Pennsylvania and Ohio in 2016, the total number of states in America allowing the use of cannabis medically is now 25. The non-state known as the District of Columbia or Washington, D.C., the nation's capitol, also has allowances for medical cannabis. They all have variations of what ailments or diseases are allowed for obtaining a medical marijuana permit. The states that are the most liberal include Colorado, Washington (state), and Oregon. They allow recreational use of marijuana, thus eliminating the need for approval from a bureaucratic medical marijuana approval system. Some states have more restrictions than others. For example, in New Mexico, hepatitis C is a condition allowed for cannabis, but only if one is using an FDA approved medically prescribed anti-viral. In other words, only as an adjunct for interferon type drugs that have a history of nasty side effects. This helps keep those who would rather avoid the medical system in it. Nearby Arizona allows cannabis for hepatitis C without the concurrent anti-viral treatment requirement. But so far, only one state allows medical cannabis for those diagnosed with aggressive or destructive autism, Delaware. Currently, a panel within the Minnesota Department of Health has met to discuss the possibility of including autism as a qualified condition for cannabis use. If you are a Minnesota resident and wish to register your supporting opinion or parental giver story with that panel, they are open to comments until September 20th.